Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy: A Systematic Review of Existing Literature.

[1]  E. Ashley,et al.  Value of Strain Imaging and Maximal Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy. , 2017, The American journal of cardiology.

[2]  N. Smedira,et al.  Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Hypertrophic Obstructive Cardiomyopathy Patients and Preserved Left Ventricular Ejection Fraction , 2017, Journal of the American Heart Association.

[3]  T. Abraham,et al.  Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy. , 2017, The American journal of cardiology.

[4]  Jeroen J. Bax,et al.  Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy , 2017, Circulation. Cardiovascular imaging.

[5]  James D Thomas,et al.  Assessing observer variability: a user's guide. , 2017, Cardiovascular diagnosis and therapy.

[6]  A. Guner,et al.  Mechanical dispersion and global longitudinal strain by speckle tracking echocardiography: Predictors of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy , 2017, Echocardiography.

[7]  Allan Klein,et al.  A Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography. , 2017, Journal of the American College of Cardiology.

[8]  N. Funabashi,et al.  Successful MACE risk stratification in hypertrophic cardiomyopathy patients using different 2D speckle-tracking TTE approaches. , 2017, International journal of cardiology.

[9]  P. Claus,et al.  Two-dimensional speckle tracking echocardiography: standardization efforts based on synthetic ultrasound data. , 2016, European heart journal cardiovascular Imaging.

[10]  J. Moon,et al.  Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy , 2016, Heart.

[11]  James D. Thomas,et al.  Improvement in Strain Concordance between Two Major Vendors after the Strain Standardization Initiative. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  C. Rooryck,et al.  Comparison of resting and exercise echocardiographic parameters as indicators of outcomes in hypertrophic cardiomyopathy. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  Maria A. Pernetz,et al.  The prognostic value of standardized reference values for speckle-tracking global longitudinal strain in hypertrophic cardiomyopathy , 2015, The International Journal of Cardiovascular Imaging.

[14]  Milind Y. Desai,et al.  Association of Noninvasively Measured Left Ventricular Mechanics With In Vitro Muscle Contractile Performance: A Prospective Study in Hypertrophic Cardiomyopathy Patients , 2014, Journal of the American Heart Association.

[15]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[16]  T. Marwick,et al.  Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  Jeroen J. Bax,et al.  Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients , 2014, The International Journal of Cardiovascular Imaging.

[18]  Natesa G Pandian,et al.  Investigation of Global and Regional Myocardial Mechanics With 3-Dimensional Speckle Tracking Echocardiography and Relations to Hypertrophy and Fibrosis in Hypertrophic Cardiomyopathy , 2014, Circulation. Cardiovascular imaging.

[19]  T. Edvardsen,et al.  Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy , 2013, Heart.

[20]  Maiko Takahashi,et al.  Risk stratification using myocardial peak longitudinal-strain on speckle-tracking transthoracic-echocardiogram to predict major adverse cardiac events in non ischemic hypertrophic-cardiomyopathy subjects confirmed by MDCT. , 2013, International journal of cardiology.

[21]  N. Smedira,et al.  Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy. , 2013, American heart journal.

[22]  Thomas H Marwick,et al.  Normal ranges of left ventricular strain: a meta-analysis. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  T. Marwick,et al.  Association of Myocardial Deformation With Outcome in Asymptomatic Aortic Stenosis With Normal Ejection Fraction , 2012, Circulation. Cardiovascular imaging.

[24]  H. Okayama,et al.  Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. , 2012, European heart journal cardiovascular Imaging.

[25]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[26]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci , 2011, Journal of the American College of Cardiology.

[27]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[28]  G. Di Salvo,et al.  Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[29]  E. Iliodromitis,et al.  Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: a 12-month follow-up study. , 2009, American heart journal.

[30]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[31]  Scott D Flamm,et al.  Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  K. Serri,et al.  Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[33]  P. Elliott,et al.  Hypertrophic cardiomyopathy , 2004, The Lancet.

[34]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[35]  C. Lambrew,et al.  Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients , 1964, Circulation.

[36]  D TEARE,et al.  ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS , 1958, British heart journal.